Fbiagent Charged with Using Secret Recordsfor Stock Scheme
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
The Miscreants' Global Bust-Out: Preface | Deep Capture
4/12/2019 The Miscreants' Global Bust-Out: Preface | Deep Capture Home About Enter your search keywords Story of Deep Capture Michael Milken and Dendreon The Movie Mitchell Report AntiSocialMedia Data Archive Podcast Categorized | Featured Stories, The Deep Capture Campaign The Miscreants’ Global Bust-Out: Preface Posted on 28 April 2011 by Patrick Byrne “A bust-out is a scheme customarily employed by organized crime to deplete the assets of a legit imate business, thus forcing it into bankruptcy.” State of New Jersey Commission of Investigation 1988 Report, “Subversion By Organized Crime And Other Unscrupulous Elements of the Check Cashing Industry” “BUSTOUT: a confidence scheme in which an established business is taken over, a large stock of merchandise is purchased on credit and quickly sold, and the business is then abandoned or bankruptcy is declared.” – Merriam-Webster Dictionary Mark Mitchell has continued exploring the financial instability of the last four years, including the crash of 2008 and the Flash Crash of 2010. His conclusion is that various activities associated with market manipulation (e.g., naked short selling, high frequency trading, derivatives such as Credit Default Swaps and synthetic CDOs, sponsored access, regulatory capture, press manipulation) follow a familiar leverage-and-loot pattern and can be traced to a fairly cohesive network that includes Italian and Russian organized crime, Sunni extremist financiers with ties to Al Qaeda, the Russian FSB, the Albanian Mafia, agents of the Iranian regime, and close associates of Michael Milken. The result, “The Miscreants’ Global Bust-Out”, is 230 pages long. DeepCapture will be publishing it in approximately 25 installments over the coming weeks. -
X UNITED STATES of AMERICA : : V
Case 1:02-cr-00589-RJD Document 502-1 Filed 12/23/2005 Page 1 of 117 UNITED STATES DISTRICT COURT EASTERN DISTRICT OF NEW YORK --------------------------------------------------------------------x UNITED STATES OF AMERICA : : v. : Cr. No. 02 - 589 (S-2) (RJD) : Cr. No. 04 - 652 (RJD) ANTHONY (AMR) ELGINDY, : Defendant. : --------------------------------------------------------------------x SENTENCING MEMORANDUM ON BEHALF OF ANTHONY (AMR) ELGINDY Barry H. Berke, Esq. Eric A. Tirschwell, Esq. Erin A. Walter, Esq. KRAMER LEVIN NAFTALIS AND FRANKEL LLP 1177 Avenue of the Americas New York, New York 10036 (212) 715-9100 Attorneys for Defendant Anthony Elgindy KL3:2460366.14 Case 1:02-cr-00589-RJD Document 502-1 Filed 12/23/2005 Page 2 of 117 Table of Contents Page I. INTRODUCTION ...............................................................................................................1 II. ANALYSIS OF THE § 3553(a) FACTORS .......................................................................8 A. Section 3553(a)(1): History and Characteristics of Anthony Elgindy.................................9 1. Anthony Elgindy’s Childhood, Education and Early Employment.........................9 2. Anthony Elgindy Evolves from a Long to a Short. ...............................................14 3. Anthony Elgindy Has Provided Compassionate Assistance to Others..................21 4. Anthony Elgindy’s Struggles with Bipolar Disorder.............................................27 5. The September 11th Stigma and the Government’s Investigation and Prosecution -
India's Biggest Scams
India's biggest scams The Satyam Computer Services fraud is neither the first nor will it be the last corporate scam to have hit India, so investors must be on guard and ask for more information before making any investment decision, says former Sebi chairman M Damodaran. Sound advice. But with corporates, brokers, banks, politicians, regulators colluding at times, many a multi-crore scam has hit India. And the saga is likely to go on. India has seen some of the most high-profile scandals where investors have lost billions of rupees just because a few people in high places could not control their greed.The Satyam Computer Services fraud is neither the first nor will it be the last corporate scam to have hit India, so investors must be on guard and ask for more information before making any investment decision, says former Sebi chairman M Damodaran. Sound advice. But with corporates, brokers, banks, politicians, regulators colluding at times, many a multi-crore scam has hit India. And the saga is likely to go on. India has seen some of the most high-profile scandals where investors have lost billions of rupees just because a few people in high places could not control their greed. Here's more about India's biggest scams... 1. Ramalinga Raju The biggest corporate scam in India has come from one of the most respected businessmen. Satyam founder Byrraju Ramalinga Raju resigned as its chairman after admitting to cooking up the account books. His efforts to fill the "fictitious assets with real ones" through Maytas acquisition failed, after which he decided to confess the crime. -
The Story of Deep Capture
The Columbia School of Journalism is our nation’s finest. They grant the Pulitzer Prize, and their journal, The Columbia Journalism Review, is the profession’s gold standard. CJR reporters are high priests of a decaying temple, tending a flame in a land going dark. In 2006 a CJR editor (a seasoned journalist formerly with Time magazine in Asia, The Wall Street Journal Europe, and The Far Eastern Economic Review) called me to discuss suspicions he was forming about the US financial media. I gave him leads but warned, “Chasing this will take you down a rabbit hole with no bottom.” For months he pursued his story against pressure and threats he once described as, “something out of a Hollywood B movie, but unlike the movies, the evil corporations fighting the journalist are not thugs burying toxic waste, they are Wall Street and the financial media itself.” His exposé reveals a circle of corruption enclosing venerable Wall Street banks, shady offshore financiers, and suspiciously compliant reporters at The Wall Street Journal, Fortune, CNBC, and The New York Times. If you ever wonder how reporters react when a journalist investigates them (answer: like white-collar crooks they dodge interviews, lie, and hide behind lawyers), or if financial corruption interests you, then this is for you. It makes Grisham read like a book of bedtime stories, and exposes a scandal that may make Enron look like an afternoon tea. By Patrick M. Byrne, Deep Capture Reporter The Story of Deep Capture By Mark Mitchell, with reporting by the Deep Capture Team Introduction - by Mark Mitchell I began working on a version of this story in January 2006, while serving as an editor for the Columbia Journalism Review, a publication tasked with upholding the standards of the American media. -
Investing Online for Dummies, 6Th Edition
01_228029 ffirs.qxp 11/16/07 11:36 PM Page i Investing Online FOR DUMmIES‰ 6TH EDITION by Matt Krantz 01_228029 ffirs.qxp 11/16/07 11:36 PM Page i Investing Online FOR DUMmIES‰ 6TH EDITION by Matt Krantz 01_228029 ffirs.qxp 11/16/07 11:36 PM Page ii Investing Online For Dummies,® 6th Edition Published by Wiley Publishing, Inc. 111 River Street Hoboken, NJ 07030-5774 www.wiley.com Copyright © 2008 by Wiley Publishing, Inc., Indianapolis, Indiana Published by Wiley Publishing, Inc., Indianapolis, Indiana Published simultaneously in Canada No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, mechanical, photocopying, recording, scanning or otherwise, except as permitted under Sections 107 or 108 of the 1976 United States Copyright Act, without either the prior written permis- sion of the Publisher, or authorization through payment of the appropriate per-copy fee to the Copyright Clearance Center, 222 Rosewood Drive, Danvers, MA 01923, (978) 750-8400, fax (978) 646-8600. Requests to the Publisher for permission should be addressed to the Legal Department, Wiley Publishing, Inc., 10475 Crosspoint Blvd., Indianapolis, IN 46256, (317) 572-3447, fax (317) 572-4355, or online at http://www. wiley.com/go/permissions. Trademarks: Wiley, the Wiley Publishing logo, For Dummies, the Dummies Man logo, A Reference for the Rest of Us!, The Dummies Way, Dummies Daily, The Fun and Easy Way, Dummies.com, and related trade dress are trademarks or registered trademarks of John Wiley & Sons, Inc. and/or its affiliates in the United States and other countries, and may not be used without written permission. -
Comment Letter
During June and July of 2009 Deep Capture serialized a 48,000 word story about a network of market miscreants that includes disreputable financial analysts, prominent journalists, some of America’s best-known hedge fund managers, associates of the Mafia, and Michael Milken, the famous criminal from the 1980s. The story focuses on the travails of Dendreon, a company with a promising treatment for prostate cancer, but it describes market machinations that have affected hundreds of other companies, and it contains a larger message about the “deep capture” of our nation’s media and regulatory bodies. Now we publish the full, 15-chapter story as a single document…. * * * * * * * * This story, like too many others, begins with Jim Cramer, the CNBC personality, making “a mistake.” On September 26, 2005, Cramer announced to his television audience the sad news (punctuated by funny sound effects – a clown horn, a crashing airplane) that Provenge, an experimental treatment for prostate cancer, had flopped. Thousands of end-stage patients had been pinning their hopes on Provenge, but according to Cramer the treatment had just been rejected by the Food & Drug Administration. It would never go to market. This seemed odd, because Dendreon (NASDAQ: DNDN), the company developing Provenge, had not yet submitted an application for FDA approval. As everybody in the biotech investment community knew, in fact, Dendreon had only recently completed Phase 3 clinical trials and probably would not face scrutiny from an FDA advisory panel for at least another year. As for the likelihood that the advisory panel would eventually vote in favor of Provenge, the odds looked good.